Pages that link to "Q43017711"
Jump to navigation
Jump to search
The following pages link to Holger Jahn (Q43017711):
Displaying 50 items.
- Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus (Q24290842) (← links)
- Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers (Q28477629) (← links)
- Involvement of NMDA receptors in alcohol-mediated behavior: mice with reduced affinity of the NMDA R1 glycine binding site display an attenuated sensitivity to ethanol (Q28585104) (← links)
- Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease (Q30430034) (← links)
- Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. (Q31004962) (← links)
- Alpha-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats. (Q32062311) (← links)
- Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment (Q33895227) (← links)
- Suicide attempts with mirtazapine overdose without complications. (Q34479125) (← links)
- Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study (Q35012646) (← links)
- Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping study (Q35610026) (← links)
- MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease (Q35629123) (← links)
- Pharmacological treatment of non-Alzheimer dementias. (Q36609184) (← links)
- Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response (Q36813361) (← links)
- Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease (Q37241399) (← links)
- Use of proteomic methods in the analysis of human body fluids in Alzheimer research (Q38060574) (← links)
- A novel presenilin 1 mutation (Ala275Val) as cause of early-onset familial Alzheimer disease (Q38392720) (← links)
- Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network (Q39990508) (← links)
- The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment (Q40410694) (← links)
- High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types (Q42250827) (← links)
- Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia (Q42374123) (← links)
- Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men. (Q43017632) (← links)
- CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks (Q43069783) (← links)
- Augmented stress-induced alcohol drinking and withdrawal in mice lacking functional natriuretic peptide-A receptors (Q43261463) (← links)
- Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings (Q43570640) (← links)
- Leptin: a modulator of alcohol craving? (Q43593941) (← links)
- Leptin as a possible modulator of craving for alcohol (Q43601381) (← links)
- Free-choice alcohol consumption in mice after application of the appetite regulating peptide leptin (Q43616577) (← links)
- Activation of guanylate cyclase by natriuretic peptides in mouse pituitary AtT20 cells is influenced by phosphorylation of ANP. (Q43713013) (← links)
- Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men. (Q43832859) (← links)
- Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. (Q43990766) (← links)
- Alcohol intake, tumour necrosis factor-alpha, leptin and craving: factors of a possibly vicious circle? (Q44054946) (← links)
- Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? (Q44097985) (← links)
- Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship (Q44196931) (← links)
- The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone (Q44530572) (← links)
- Acute effects of megestrol on the hypothalamic-pituitary-adrenal axis (Q44589093) (← links)
- Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease (Q44846425) (← links)
- Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings (Q44910834) (← links)
- Diabetes mellitus as a complication of treatment with atypical neuroleptics. Possible pathomechanisms and treatment recommendations (Q44977945) (← links)
- Adjunctive use of reboxetine in schizophrenia (Q45055718) (← links)
- Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial (Q45176708) (← links)
- Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes (Q45236056) (← links)
- A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. (Q46006742) (← links)
- Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease (Q46121140) (← links)
- Pharmacological relapse prevention of alcoholism: clinical predictors of outcome (Q46398877) (← links)
- Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone (Q46423269) (← links)
- Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease (Q46490254) (← links)
- Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism (Q46578689) (← links)
- A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment (Q46605304) (← links)
- Capillary electrophoresis mass spectrometry as a potential tool to detect lithium-induced nephropathy: Preliminary results (Q46835601) (← links)
- Megestrol attenuates the hormonal response to CCK-4-induced panic attacks (Q46938208) (← links)